Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial

Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-02T13:14:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition to using “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) in agency content.
    Difference
    0.3%
    Check dated 2026-10-26T15:21:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-19T14:55:02.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-12T16:00:05.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision history now lists the latest entry as v3.7.0 and removes the previous v3.6.6 entry, updating the version trail for the study record. This reflects an update to the page's metadata rather than changes to study design, results, or participant information.
    Difference
    0.0%
    Check dated 2026-09-21T22:25:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The record history revision was updated from v3.6.5 to v3.6.6, indicating a maintenance update to the page’s version history.
    Difference
    0.0%
    Check dated 2026-08-31T17:36:46.000Z thumbnail image

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.